Whitehawk Therapeutics (WHWK) Preferred Dividend Payments (2016 - 2017)
Whitehawk Therapeutics' (WHWK) quarterly Preferred Dividend Payments came in at $943297.0 in Q1 2017, down 7.1% year-on-year from $1.0 million in Q1 2016, and down 10.56% on a QoQ basis from $1.1 million in Q4 2016.
Whitehawk Therapeutics (WHWK) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Preferred Dividend Payments data on file, last reported at $943297.0 in Q1 2017.
- On a quarterly basis, Preferred Dividend Payments fell 7.1% year-over-year to $943297.0 in Q1 2017; TTM through Dec 2017 was $943297.0, a 77.29% decrease from a year earlier, with the FY2021 full-year figure at $647000.0, changed N/A from the prior year.
- Preferred Dividend Payments for Q1 2017 stood at $943297.0, down from $1.1 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for WHWK reached as high as $1.1 million in Q3 2016 and fell as low as $943297.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 943,297.00 |
| Dec 31, 2016 | 1.05 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.03 Mn |
| Mar 31, 2016 | 1.02 Mn |